By Natural Capital
Varda Space Industries secured $187 million in funding, led by Natural Capital and Shrug Capital, to advance robotic drug manufacturing in space. This investment will enable Varda to increase flight frequency and develop a pharmaceutical lab for microgravity-enabled drug formulations.